The Ability of Some Inorganic Nanoparticles to Inhibit Some <em>Staphylococcus</em> spp.

In the last decades, antibiotics were used to treat infections caused by some Staphylococcus species, especially Staphylococcus aureus and Staphylococcus epidermidis. The widespread use of antibiotics to treat staphylococcal infections has resulted in an increase in the resistance of bacteria to antibiotics, particularly to beta-lactam antibiotics. In recent years, researchers have been working on developing new antibiotics, despite the fact that they are complex and expensive and carry a number of risks associated with drug toxicity. Using new substances that have good potential against bacterial infection without causing bacteria to become resistant to these substances is currently being researched. More research has been carried out on the effect of silver and copper nanoparticles in neutralizing staphylococcal infection in laboratory studies. The toxic effect of nanoparticles was a concern to scientists, but despite that, the studies in vivo found that there was no toxic effect at low doses of nanoparticles on rats. The findings in this field were acceptable to entice researchers to develop these substances